Redox state in mediating methylmercury neurotoxicity

Methylmercury and Neurotoxicity

Volumn , Issue , 2012, Pages 101-125

  Farina, Marcelo ^a   Aschner, Michael ^b   Rocha, João B T ^c  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85026569895     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-2383-6_6     Document Type: Chapter

References (144)

1. Aizenman E, Lipton SA, Loring RH. Selective modulation of NMDA responses by reduction and oxidation. Neuron. 1989;2:1257-63.
2. Allen JW, Mutkus LA, Aschner M. Methylmercury-mediated inhibition of 3H-D-aspartate transport in cultured astrocytes is reversed by the antioxidant catalase. Brain Res. 2001;902: 92-100.
3. Allen JW, Shanker G, Aschner M. Methylmercury inhibits the in vitro uptake of the glutathione precursor, cystine, in astrocytes, but not in neurons. Brain Res. 2001;894:131-40.
4. Araie H, Shiraiwa Y. Selenium utilization strategy by microalgae. Molecules. 2009;14:4880-91.
5. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci. 1994;14:5559-69.
6. Asahina M, Yamada T, Yoshiyama Y, Yodoi J. Expression of adult T cell leukemia-derived factor in human brain and peripheral nerve tissues. Dement Geriatr Cogn Disord. 1998;9:181-5.
7. Aschner M, Eberle NB, Goderie S, Kimelberg HK. Methylmercury uptake in rat primary astrocyte cultures: the role of the neutral amino acid transport system. Brain Res. 1990;521:221-8.
8. Aschner M, Mullaney KJ, Wagoner D, Lash LH, Kimelberg HK. Intracellular glutathione (GSH) levels modulate mercuric chloride (MC)- and methylmercuric chloride (MeHgCl)-induced amino acid release from neonatal rat primary astrocytes cultures. Brain Res. 1994;664:133-40.
9. Aschner M, Yao CP, Allen JW, Tan KH. Methylmercury alters glutamate transport in astrocytes. Neurochem Int. 2000;37:199-206.
10. Ballatori N, Clarkson TW. Developmental changes in the biliary excretion of methylmercury and glutathione. Science. 1982;216:61-3.
11. Barber DS, LoPachin RM. Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes. Toxicol Appl Pharmacol. 2004;201:120-36.
12. Basu N, Scheuhammer AM, Rouvinen-Watt K, Evans RD, Grochowina N, Chan LHM. The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink. Neurotoxicology. 2008;29:328-34.
13. Berman SB, Hastings TG. Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J Neurochem. 1997;69:1185-95.
14. Braestrup C, Andersen PH. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site. J Neurochem. 1987;48:1667-72.
15. Branco V, Canário J, Holmgren A, Carvalho C. Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury. Toxicol Appl Pharmacol. 2011;251:9.
16. Brookes N, Kristt DA. Inhibition of amino acid transport and protein synthesis by HgCl2 and methylmercury in astrocytes: selectivity and reversibility. J Neurochem. 1989;53:1228-37.
17. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484-90.
18. Carvalho MC, Franco JL, Ghizoni H, et al. Effects of 2, 3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice. Toxicology. 2007;239:195-203.
19. Chen J, Berry MJ. Selenium and selenoproteins in the brain and brain diseases. J Neurochem. 2003;86:1-12.
20. Cidon S, Sihra TS. Characterization of a Hh-ATPase in rat brain synaptic vesicles. Coupling to L-glutamate transport. J Biol Chem. 1989;264:8281-8.
21. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48:749-62.
22. Clarkson TW, Magos L, Myers GJ. The toxicology of mercury-current exposures and clinical manifestations. N Engl J Med. 2003;349:1731-7.
23. Clavreul N, Adachi T, Pimental DR, Ido Y, Schoneich C, Cohen RA. S-glutathiolation by per- oxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J. 2006;20:518-20.
24. Coccini T, Randine G, Candura SM, Nappi RE, Prockop LD, Manzo L. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring. Environ Health Perspect. 2000;108:29-33.
25. Compeau GC, Bartha R. Sulfate-reducing bacteria: principal methylators of mercury in anoxic estuarine sediment. Appl Environ Microbiol. 1985;50:498-502.
26. Cooper AJ, Kristal BS. Multiple roles of glutathione in the central nervous system. Biol Chem. 1997;378:793-802.
27. Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OP. Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol. 2004;44:87-110.
28. Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC. Lack of glutathione peroxidase-1 exacerbates Abeta-mediated neurotoxicity in cortical neurons. J Neural Transm. 2006;113:645-57.
29. Cuvin-Aralar ML, Furness RW. Mercury and selenium interaction: a review. Ecotoxicol Environ Saf. 1991;21:348-64.
30. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci. 2009;34:85-96.
31. Daré E, Fetissov S, Hökfelt T, Hall H, Ögren SO, Ceccatelli S. Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding. Naunyn-Schmiedebergs Arch Pharmacol. 2003;367:500-8.
32. de Freitas AS, Funck VR, Rotta Mdos S, et al. Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice. Brain Res Bull. 2009;79:77-84.
33. Debes F, Budtz-Jørgensen E, Weihe P, White RF, Grandjean P. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol. 2006;28: 363-75.
34. Dreiem A, Shan M, Okoniewski RJ, Sanchez-Morrissey S, Seegal RF. Methylmercury inhibits dopaminergic function in rat pup synaptosomes in an age-dependent manner. Neurotoxicol Teratol. 2009;31:312-7.
35. Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem. 2003;384:505-16.
36. Dringen R, Pawlowski PG, Hirrlinger J. Peroxide detoxification by brain cells. J Neurosci Res. 2005;79:157-65.
37. Farina M, Rocha JBT, Aschner M. Oxidative stress and methylmercury-induced neurotoxicity. Indianapolis: John Wiley & Sons; 2010.
38. Farina M, Brandao R, de Lara FS, et al. Profile of nonprotein thiols, lipid peroxidation and delta- aminolevulinate dehydratase activity in mouse kidney and liver in response to acute exposure to mercuric chloride and sodium selenite. Toxicology. 2003;184:179-87.
39. Farina M, Campos F, Vendrell I, et al. Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. Toxicol Sci. 2009;112:416-26.
40. Farina M, Dahm KC, Schwalm FD, et al. Methylmercury increases glutamate release from brain synaptosomes and glutamate uptake by cortical slices from suckling rat pups: modulatory effect of ebselen. Toxicol Sci. 2003;73:135-40.
41. Farina M, Franco JL, Ribas CM, et al. Protective effects of Polygala paniculata extract against methylmercury-induced neurotoxicity in mice. J Pharm Pharmacol. 2005;57:1503-8.
42. Farina M, Frizzo ME, Soares FA, et al. Ebselen protects against methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice. Toxicol Lett. 2003;144:351-7.
43. Feng Y, Forgac M. Cysteine 254 of the 73-kDa A subunit is responsible for inhibition of the coated vesicle (H+)-ATPase upon modification by sulfhydryl reagents. J Biol Chem. 1992;267:5817-22.
44. Flohe L. Glutathione peroxidase. Basic Life Sci. 1988;49:663-8.
45. Forgac M. Structure and function of vacuolar class of ATP-driven proton pumps. Physiol Rev. 1989;69:765-96.
46. Franco JL, Braga HC, Stringati J, et al. Mercurial-induced hydrogen peroxide generation in mouse brain mitochondria: protective effects of quercetin. Chem Res Toxicol. 2007;20:1919-26.
47. Franco JL, Posser T, Dunkley PR, et al. Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radic Biol Med. 2009;47:449-57.
48. Franco JL, Teixeira A, Meotti FC, et al. Cerebellar thiol status and motor deficit after lactational exposure to methylmercury. Environ Res. 2006;102:22-8.
49. Freitas AJ, Rocha JB, Wolosker H, Souza DO. Effects of Hg2+ and CH3Hg+ on Ca2+ fluxes in rat brain microsomes. Brain Res. 1996;738:257-64.
50. Fujimura M, Usuki F, Kawamura M, Izumo S. Inhibition of the Rho/ROCK pathway prevents neuronal degeneration in vitro and in vivo following methylmercury exposure. Toxicol Appl Pharmacol. 2011;250(1):1-9.
51. Fujimura M, Usuki F, Sawada M, Rostene W, Godefroy D, Takashima A. Methylmercury exposure downregulates the expression of Racl and leads to neuritic degeneration and ultimately apoptosis in cerebrocortical neurons. Neurotoxicology. 2009;30:16-22.
52. Fujiyama J, Hirayama K, Yasutake A. Mechanism of methylmercury efflux from cultured astrocytes. Biochem Pharmacol. 1994;47:1525-30.
53. Ghezzi P. Regulation of protein function by glutathionylation. Free Radic Res. 2005;39:573-80.
54. Glaser V, Leipnitz G, Straliotto MR, et al. Oxidative stress-mediated inhibition of brain creatine kinase activity by methylmercury. Neurotoxicology. 2010;31:454-60.
55. Glover CN, Zheng D, Jayashankar S, Sales GD, Hogstrand C, Lundebye AK. Methylmercury speciation influences brain gene expression and behavior in gestationally-exposed mice pups. Toxicol Sci. 2009;110:389-400.
56. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997;19:417-28.
57. Gul M, Kutay FZ, Temocin S, Hanninen O. Cellular and clinical implications of glutathione. Indian J Exp Biol. 2000;38:625-34.
58. Hattori F, Oikawa S. Peroxiredoxins in the central nervous system. Subcell Biochem. 2007;44:357-74.
59. Hattori I, Takagi Y, Nakamura H, et al. Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice. Antioxid Redox Signal. 2004;6:81-7.
60. 3-aminobutyric acid type a receptor currents in rat cerebellar granule and cerebral cortical neurons in culture. J Pharmacol Exp Ther. 2008;324:517-28.
61. Hintelmann H. Organomercurials. Their formation and pathways in the environment. Met Ions Life Sci. 2010;7:365-401.
62. Holmgren A, Luthman M. Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry. 1978;17:4071-7.
63. Hüttemann M, Lee I, Pecinova A, Pecina P, Przyklenk K, Doan J. Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J Bioenerg Biomembr. 2008;40:445-56.
64. Jones C. Sulfur in proteins. In: Torchinsky YM (translated by W Wittenberg). Biochemical Education. Pergamon Press: Oxford; 1981. p 294. (original in Russian, 1977). ($96 ISBN 0-08023778-9. 1982;10:123.
65. Jones DP, Go Y-M, Anderson CL, Ziegler TR, Kinkade JJM, Kirlin WG. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J. 2004; 18(11): 1246-8.
66. Juarez BI, Martinez ML, Montante M, Dufour L, Garcia E, Jimenez-Capdeville ME. Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats. Neurotoxicol Teratol. 2002;24:767-71.
67. Julvez J, Debes F, Weihe P, Choi A, Grandjean P. Sensitivity of continuous performance test (CPT) at age 14years to developmental methylmercury exposure. Neurotoxicol Teratol. 2010;32:627-32.
68. Kanai Y, Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 1992;360:467-71.
69. Kaur P, Aschner M, Syversen T. Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. Neurotoxicology. 2006;27:492-500.
70. Kaur P, Aschner M, Syversen T. Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology. 2007;230:164-77.
71. Keller JE, Bravo DT, Parsons SM. modification of cysteines reveals linkage to acetylcholine and vesamicol binding sites in the vesicular acetylcholine transporter of Torpedo californica. J Neurochem. 2000;74:1739-48.
72. Kemmerling U, Munoz P, Muller M, et al. Calcium release by ryanodine receptors mediates hydrogen peroxide-induced activation of ERK and CREB phosphorylation in N2a cells and hippocampal neurons. Cell Calcium. 2007;41:491-502.
73. Kenow KP, Hoffman DJ, Hines RK, et al. Effects of methylmercury exposure on glutathione metabolism, oxidative stress, and chromosomal damage in captive-reared common loon (Gavia immer) chicks. Environ Pollut. 2008;156:732-8.
74. Kerper LE, Mokrzan EM, Clarkson TW, Ballatori N. Methylmercury efflux from brain capillary endothelial cells is modulated by intracellular glutathione but not ATP. Toxicol Appl Pharmacol. 1996;141:526-31.
75. Khan MA, Wang F. Mercury-selenium compounds and their toxicological significance: toward a molecular understanding of the mercury-selenium antagonism. Environ Toxicol Chem. 2009;28:1567-77.
76. Kim SO, Merchant K, Nudelman R, et al. OxyR: a molecular code for redox-related signaling. Cell. 2002;109:383-96.
77. Kiskin NI, Krishtal OA, Tsyndrenko A, Akaike N. Are sulfhydryl groups essential for function of the glutamate-operated receptor-ionophore complex? Neurosci Lett. 1986;66:305-10.
78. Kung MP, Kostyniak P, Olson J, Malone M, Roth JA. Studies of the in vitro effect of methylmer- cury chloride on rat brain neurotransmitter enzymes. J Appl Toxicol. 1987;7:119-21.
79. Laube B, Kuryatov A, Kuhse J, Betz H. Glycine-glutamate interactions at the NMDA receptor: role of cysteine residues. FEBS Lett. 1993;335:331-4.
80. Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA. 2000;97:2521-6.
81. Lee S-R, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA. 2000;97:2521-6.
82. Lipton SA, Choi YB, Takahashi H, et al. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci. 2002;25:474-80.
83. Lobanov AV, Fomenko DE, Zhang Y, Sengupta A, Hatfield DL, Gladyshev VN. Evolutionary dynamics of eukaryotic selenoproteomes: large selenoproteomes may associate with aquatic life and small with terrestrial life. Genome Biol. 2007;8:R198.
84. Lobanov AV, Hatfield DL, Gladyshev VN. Eukaryotic selenoproteins and selenoproteomes. Biochim Biophys Acta. 2009;1790:1424-8.
85. LoPachin RM. The changing view of acrylamide neurotoxicity. Neurotoxicology. 2004;25: 617-30.
86. LoPachin RM, Barber DS. Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Toxicol Sci. 2006;94:240-55.
87. Lu J, Holmgren A. Selenoproteins. J Biol Chem. 2009;284:723-7.
88. Luthman M, Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry. 1982;21:6628-33.
89. Ma S, Caprioli RM, Hill KE, Burk RF. Loss of selenium from selenoproteins: conversion of sele- nocysteine to dehydroalanine in vitro. J Am Soc Mass Spectrom. 2003;14:593-600.
90. Maekawa M, Satoh S, Murayama T, Nomura Y. Involvement of Hg2+-sensitive sulfhydryl groups in regulating noradrenaline release induced by S-nitrosocysteine in rat brain slices. Biochem Pharmacol. 2000;59:839-45.
91. Magos L, Webb M. The interactions of selenium with cadmium and mercury. Crit Rev Toxicol. 1980;8:1-42.
92. Malagutti KS, da Silva AP, Braga HC, et al. 17[beta]-estradiol decreases methylmercury-induced neurotoxicity in male mice. Environ Toxicol Pharmacol. 2009;27:293-7.
93. Manfroi CB, Schwalm FD, Cereser V, et al. Maternal milk as methylmercury source for suckling mice: neurotoxic effects involved with the cerebellar glutamatergic system. Toxicol Sci. 2004;81:172-8.
94. Marsh DO, Clarkson TW, Myers GJ, et al. The Seychelles study of fetal methylmercury exposure and child development: introduction. Neurotoxicology. 1995;16:583-96.
95. McCord JM. Superoxide dismutase in aging and disease: an overview. Methods Enzymol. 2002;349:331-41.
96. Meister A. Glutathione metabolism. Methods Enzymol. 1995;251:3-7.
97. Meyer Y, Buchanan BB, Vignols F, Reichheld JP. Thioredoxins and glutaredoxins: unifying elements in redox biology. Annu Rev Genet. 2009;43:335-67.
98. Moretto MB, Funchal C, Santos AQ, et al. Ebselen protects glutamate uptake inhibition caused by methyl mercury but does not by Hg2+. Toxicology. 2005;214:57-66.
99. Moretto MB, Funchal C, Zeni G, Pessoa-Pureur R, Rocha JB. Selenium compounds prevent the effects of methylmercury on the in vitro phosphorylation of cytoskeletal proteins in cerebral cortex of young rats. Toxicol Sci. 2005;85:639-46.
100. Murata K, Dakeishi M, Shimada M, Satoh H. Assessment of intrauterine methylmercury exposure affecting child development: messages from the newborn. Tohoku J Exp Med. 2007;213:187-202.
101. Mustacich D, Powis G. Thioredoxin reductase. Biochem J. 2000;346(Pt 1):1-8.
102. Nogueira CW, Rocha JBT. Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds. Arch Toxicol. 2011;85(11):1313-59.
103. Nogueira CW, Rocha JBT. Diphenyl diselenide a janus-faced molecule. J Braz Chem Soc. 2010;21:2055-71.
104. Nogueira CW, Zeni G, Rocha JB. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev. 2004;104:6255-85.
105. Patenaude A, Murthy MR, Mirault ME. Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol Life Sci. 2005;62:1063-80.
106. Pearson RG, Songstad J. Application of the principle of hard and soft acids and bases to organic chemistry. J Am Chem Soc. 1967;89:1827-36.
107. Porciuncula LO, Rocha JB, Tavares RG, Ghisleni G, Reis M, Souza DO. Methylmercury inhibits glutamate uptake by synaptic vesicles from rat brain. Neuroreport. 2003;14:577-80.
108. Prabhakar R, Morokuma K, Musaev DG. Peroxynitrite reductase activity of selenoprotein glutathione peroxidase: â%o a computational study â%o. Biochemistry. 2006;45:6967-77.
109. Prohaska JR, Ganther HE. Selenium and glutathione peroxidase in developing rat brain. J Neurochem. 1976;27:1379-87.
110. Rabenstein DL, Isab AA, Reid RS. A proton nuclear magnetic resonance study of the binding of methylmercury in human erythrocytes. Biochim Biophys Acta. 1982;720:53-64.
111. Reis HJ, Gomez MV, Kalapothakis E, et al. Inhibition of glutamate uptake by Tx3-4 is dependent on the redox state of cysteine residues. Neuroreport. 2000;11:2191-4.
112. Rocha JB, Freitas AJ, Marques MB, Pereira ME, Emanuelli T, Souza DO. Effects of methylmercury exposure during the second stage of rapid postnatal brain growth on negative geotaxis and on delta-aminolevulinate dehydratase of suckling rats. Braz J Med Biol Res. 1993;26:1077-83.
113. Rybnikova E, Damdimopoulos AE, Gustafsson JA, Spyrou G, Pelto-Huikko M. Expression of novel antioxidant thioredoxin-2 in the rat brain. Eur J Neurosci. 2000;12:1669-78.
114. Sarafian TA, Bredesen DE, Verity MA. Cellular resistance to methylmercury. Neurotoxicology. 1996;17:27-36.
115. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30:1191-212.
116. Schwarz K, Foltz CM. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc. 1957;79:3292-3.
117. Schweizer U, Schomburg L, Savaskan NE. The neurobiology of selenium: lessons from transgenic mice. J Nutr. 2004;134:707-10.
118. Seres T, Ravichandran V, Moriguchi T, Rokutan K, Thomas JA, Johnston RB Jr. Protein S-thiolation and dethiolation during the respiratory burst in human monocytes. A reversible post-translational modification with potential for buffering the effects of oxidant stress. J Immunol. 1996;156:1973-80.
119. Shanker G, Allen JW, Mutkus LA, Aschner M. Methylmercury inhibits cysteine uptake in cultured primary astrocytes, but not in neurons. Brain Res. 2001;914:159-65.
120. Shanker G, Syversen T, Aschner JL, Aschner M. Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. Brain Res Mol Brain Res. 2005;137:11-22.
121. Sidhu A, Kassis S, Kebabian J, Fishman PH. Sulfhydryl group(s) in the ligand binding site of the D-1 dopamine receptor: specific protection by agonist and antagonist. Biochemistry. 1986;25:6695-701.
122. Simpson RB. Association constants of methylmercury with sulfhydryl and other bases. J Am Chem Soc. 1961;83:4711-7.
123. Soares FA, Farina M, Santos FW, Souza D, Rocha JB, Nogueira CW. Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes. Neurochem Res. 2003;28:1859-65.
124. Stringari J, Nunes AK, Franco JL, et al. Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol. 2008;227:147-54.
125. Sugiura Y, Hojo Y, Tamai Y, Tanaka H. Selenium protection against mercury toxicity. Binding of methylmercury by the selenohydryl-containing ligand. J Am Chem Soc. 1976;98:2339-41.
126. Sumi D. Biological effects of and responses to exposure to electrophilic environmental chemicals. J Health Sci. 2008;54:6.
127. Tabatabaie T, Potts JD, Floyd RA. Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase. Arch Biochem Biophys. 1996;336:290-6.
128. Takagi Y, Hattori I, Nozaki K, et al. Excitotoxic hippocampal injury is attenuated in thioredoxin transgenic mice. J Cereb Blood Flow Metab. 2000;20:829-33.
129. Takagi Y, Mitsui A, Nishiyama A, et al. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA. 1999;96:4131-6.
130. Trotti D, Rizzini BL, Rossi D, et al. Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci. 1997;9:1236-43.
131. Trotti D, Rossi D, Gjesdal O, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem. 1996;271:5976-9.
132. Tsuzuki Y, Yamada T. Inhibitory actions of mercury compounds against glucose-6-phosphate dehydrogenase from yeast. J Toxicol Sci. 1979;4:105-13.
133. Usuki F, Yamashita A, Fujimura M. Post-transcriptional defects of antioxidant selenoenzymes cause oxidative stress under methylmercury exposure. J Biol Chem. 2011;286:6641-9.
134. Vina J, Hems R, Krebs HA. Maintenance of glutathione content is isolated hepatocyctes. Biochem J. 1978;170:627-30.
135. Volz TJ, Schenk JO. A comprehensive atlas of the topography of functional groups of the dopamine transporter. Synapse. 2005;58:72-94.
136. Wagner C, Sudati JH, Nogueira CW, Rocha JB. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury. Biometals. 2010;23:1171-7.
137. Wang PF, McLeish MJ, Kneen MM, Lee G, Kenyon GL. An unusually low pK(a) for Cys282 in the active site of human muscle creatine kinase. Biochemistry. 2001;40:11698-705.
138. Washburn MP, Wells WW. The catalytic mechanism of the glutathione-dependent dehydroascorbate reductase activity of thioltransferase (glutaredoxin). Biochemistry. 1999;38:268-74.
139. Wolf M, Baynes J. Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals. 2007;20:73-81.
140. Ying J, Tong X, Pimentel DR, et al. Cysteine-674 of the sarco/endoplasmic reticulum calcium ATPase is required for the inhibition of cell migration by nitric oxide. Arterioscler Thromb Vasc Biol. 2007;27:783-90.
141. Yoneda S, Suzuki KT. Equimolar Hg-Se complex binds to selenoprotein P. Biochem Biophys Res Commun. 1997;231:7-11.
142. Zareba G, Cernichiari E, Hojo R, et al. Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury. J Appl Toxicol. 2007;27:511-8.
143. Zhang S, Rocourt C, Cheng WH. Selenoproteins and the aging brain. Mech Ageing Dev. 2010;131:253-60.
144. Zhu H, Zhang L, Xi X, Zweier JL, Li Y. 4-Hydroxy-2-nonenal upregulates endogenous antioxidants and phase 2 enzymes in rat H9c2 myocardiac cells: protection against overt oxidative and electrophilic injury. Free Radic Res. 2006;40:875-84.